Executive Director Quality, Cell & Gene Therapy

Role: Executive Director leading Cell & Genetic Therapies (CGT) Quality organization, responsible for defining and executing strategic quality initiatives from early development through commercialization. Responsibilities: establish scalable, inspection-ready quality systems; drive enterprise quality transformation; oversee quality in CGT programs, technical transfers, and product lifecycle management; ensure quality readiness for global market launch; lead external partnerships and regulatory interactions; build and develop a high-performing, inclusive global quality team; manage budgets, talent, and organizational strategy. Requirements: Master's or PhD in life sciences or related field; 15+ years in biotech/pharma quality, with 10+ years in leadership roles; deep knowledge of GXP compliance, cell & gene therapy manufacturing, analytics, and regulatory affairs; proven experience supporting late-stage development, commercialization, and global manufacturing. Preferred: expertise in biologics, aseptic manufacturing, and regulatory filings for cell/gene therapies. HighValue: senior leadership in CGT quality, global regulatory environment, biologics/cell/gene modalities, late-stage development, commercialization, inspection readiness, and digital quality innovation. WorkSetup: on-site five days/week; flexible arrangements as per company policy.